Patient-specific
induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
Chen, "Transplantation of
induced pluripotent stem cells without C-Myc attenuates retinal ischemia and reperfusion injury in rats," Experimental Eye Research, vol.
Oct3/4, Klf4, c-Myc and Sox2 produce
induced pluripotent stem cells. US8058065 B2.
Human iPS Cells: Human
induced pluripotent stem cells (iPSCs, cat# SC102A-1) were generated by transducing genetically unmodified human fibroblasts with viruses individually encoding the four human transcription factors (Oct4, Sox2, Klf4, and c-Myc) that have been shown to induce the reprogramming of somatic cells to a pluripotent state.
Park et al., "Generation of
induced pluripotent stem cells from human blood," Blood, vol.
Pluripotent cells fall into two groups, embryonic stem cells and
induced pluripotent stem cells. While embryonic stem cells come from human embryos, an ethically thorny issue,
induced pluripotent stem cells come from adult cells that are manipulated to be able to transform into any cell type.
They cover induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) as a novel diagnostic platform; preclinical large-animal models of cardiovascular regeneration; cell-free therapy with stem cell secretions: protection, repair, and regeneration of the injured myocardium; myoblasts as treatment for hereditary muscular dystrophies, cardiomyopathies, type 2 diabetes, solid tumors, and aging; stem cells in ophthalmology; stem cells for ocular therapies; cell therapy for liver regeneration; patient-specific
induced pluripotent stem cells for cardiac disease modeling; and the role of stem cells in evolution: a hypothesis.
There is another category called
induced pluripotent stem cells (iPSCs).
Plasticell, a biotechnology company specializing in stem cell screening and cell therapies, has entered into a collaboration with GlaxoSmithKline for the use of its stem cell screening technology, CombiCult, to optimize
induced pluripotent stem cells (iPSCs) to specific blood cell lineages for GSK's therapeutic research.
Throughout the years however, the spotlight has shifted towards a new type of stem cells; the
induced pluripotent stem cells (iPS Cells).
The objective of this study was to create a 3D hydrogel system to culture and directly differentiate human
induced pluripotent stem cells (hiPSCs) into mature, synchronously contracting engineered cardiac tissues to mimic the native heart.